• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioLine RX Ltd

+ Add to Watchlist


Price not available for BLNEF:US

Snapshot for BioLine RX Ltd (BLNEF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.2000 52wk Range: - 1-Yr Rtn: -

Stock Chart for BLNEF

No chart data available.
  • BLNEF:US 0.2000
  • 1M
  • 1Y
Interactive BLNEF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLNEF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (ILS) (ttm) -
Est. EPS (ILS) (12/2014) -0.1270
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 391.15
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLNEF

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BLNEF

BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.

Kinneret Livnat SavitskyChief Executive OfficerPhilip SerlinCFO/COO
David MalekVP:Business DevelopmentArnon AharonVP:Medical Affairs
More Company Profile & Key Executives for BLNEF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil